- Capital Cube•2 months ago
Categories: Yahoo Finance Get free summary analysis Entia Biosciences, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Entia Biosciences, Inc. – Hudson Global, Inc., Kforce Inc., TeleTech Holdings, Inc., ManpowerGroup Inc. and Insperity, Inc. (HSON-US, KFRC-US, TTEC-US, MAN-US and NSP-US) that have also reported for ... Read more (Read more...)
- GlobeNewswire•3 months agoEntia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses
PORTLAND, Ore., Nov. 02, 2016-- Entia Biosciences, Inc. has been informed that the European Patent Office has granted European Patent Number 1 761 784 with the title“ Identification of Ergothioneine Transporter ...
- Accesswire•last yearEntia Biosciences, Inc. Names Chief Executive Officer to Manage Growth of Consumer Health Products and To Launch New Medical Food Brands
New Business Strategy to Capitalize on Unique, Innovative and Proprietary Entia Products SHERWOOD, OR / ACCESSWIRE / August 13, 2015 / Entia Biosciences, Inc. (OTCQB: ERGO), today announced that Carl J. ...
ERGO : Summary for ENTIA BIOSCIENCES COM USD0.001 - Yahoo Finance
Entia Biosciences, Inc (ERGO)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.89|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|